CLDX
Celldex Therapeutics Inc
31.10$
-7.1%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -1,252.0% | -787.5% | -26,050.0% | -1,174.0% | -1,734.2% | -2,763.9% | -7,823.3% | -6,028.1% | – | -85,253.3% | -437,253.3% | -260,954.5% | -210,326.8% | |
| 50.6% | 18.4% | 496.8% | 31.9% | -363.5% | 69.7% | 124.7% | 119.6% | – | 5,185.3% | 1,493.3% | 6,963.6% | 5,775.9% | |
| 469.4% | 174.6% | 4,616.7% | 305.8% | 301.5% | 832.3% | 1,340.4% | 1,259.0% | – | 11,878.7% | 56,820.0% | 38,218.2% | 30,929.5% | |
| 857.4% | 120.6% | -8,014.1% | 112.8% | -604.6% | 627.7% | -1,222.4% | 577.7% | – | 11,378.7% | 28,980.0% | 38,545.5% | 27,825.0% | |
| 10.3% | 16.1% | 220.5% | 11.0% | 19.4% | 64.3% | 38.1% | 99.7% | – | 1,324.0% | 10,926.7% | 14,450.0% | 5,581.3% | |
| 767.7% | -4,143.3% | -202,058.3% | -1,870.4% | 1,496.6% | 2,046.6% | 6,179.9% | 6,828.8% | – | 73,900.0% | 480,793.3% | -1,161,463.6% | -59,938.4% | |
| 16.9% | 5,262.0% | 279,559.0% | 148.6% | 38.8% | 32.9% | 29.1% | 8.6% | – | 1,798.7% | 2,180.0% | 1,475,713.6% | 292,059.8% | |
| -467.4% | 331.2% | 51,450.6% | -2,895.8% | -198.7% | -684.5% | -1,614.4% | 809.3% | – | -9,554.7% | 45,720.0% | 53,295.5% | 21,794.6% | |
| -1,262.4% | -803.7% | -26,270.5% | -1,185.0% | -1,714.8% | -2,828.3% | -7,861.4% | -6,127.8% | – | -86,577.3% | -448,180.0% | -275,404.5% | -215,908.0% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.